WallStreetZen

NYSE: TMO
Thermo Fisher Scientific Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for TMO

Based on 14 analysts offering 12 month price targets for Thermo Fisher Scientific Inc.
Min Forecast
$340.00-32.42%
Avg Forecast
$495.43-1.53%
Max Forecast
$550.00+9.31%

Should I buy or sell TMO stock?

Strong Buy
Strong Buy
10 analysts 66.67%
Buy
2 analysts 13.33%
Hold
3 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Forecast return on equity

Is TMO forecast to generate an efficient return?
Company
24.36%
Industry
-0.21%
Market
60.43%
TMO's Return on Equity is forecast to be high in 2 years (24.36%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is TMO forecast to generate an efficient return on assets?
Company
12.1%
Industry
9.22%
Market
15%
TMO is forecast to generate higher Return on Assets (12.1%) than the US Diagnostics & Research industry average (9.22%)
Forecast

TMO earnings per share forecast

What is TMO's earnings per share in the next 2 years based on estimates from 10 analysts?
Avg 1 year Forecast
$19.96+62.29%
Avg 2 year Forecast
$19.60+59.33%
TMO's earnings are forecast to grow at an exceptional rate of 62.29% per year
Forecast

TMO revenue forecast

What is TMO's revenue in the next 2 years based on estimates from 7 analysts?
Avg 1 year Forecast
$33.1B+16.29%
Avg 2 year Forecast
$33.0B+15.8%
TMO's revenue is forecast to grow at a rate of 16.29% per year, which is not exceptional
Forecast

TMO earnings growth forecast

How is TMO forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
62.29%
Industry
70.99%
Market
110.74%
TMO's earnings are forecast to grow slower (62.29% per year) than the US Diagnostics & Research industry average (70.99%)
Forecast
TMO's earnings are forecast to grow slower (62.29% per year) than the US market average (110.74%)
Forecast
TMO's earnings are forecast to grow faster (62.29% per year) than the risk-free savings rate (1.1%)
Forecast

TMO revenue growth forecast

How is TMO forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
16.29%
Industry
21.21%
Market
71.81%
TMO's revenues are forecast to grow slower (16.29% per year) than the US Diagnostics & Research industry average (21.21%)
Forecast
TMO's revenues are forecast to grow slower (16.29% per year) than the US market average (71.81%)
Forecast

Thermo Fisher Scientific Stock Forecast FAQ

Is Thermo Fisher Scientific Stock a good buy in 2020, according to Wall Street analysts?

The consensus among 15 Wall Street analysts covering (NYSE: TMO) stock is to Strong Buy TMO stock.

Out of 15 analysts, 10 (66.67%) are recommending TMO as a Strong Buy, 2 (13.33%) are recommending TMO as a Buy, 3 (20%) are recommending TMO as a Hold, 0 (0%) are recommending TMO as a Sell, and 0 (0%) are recommending TMO as a Strong Sell.

What is TMO's Price Target?

According to 14 Wall Street analysts that have issued a 1 year TMO price target, the average TMO price target is $495.43, with the highest TMO stock price forecast at $550.00 and the lowest TMO stock price forecast at $340.00.

On average, Wall Street analysts predict that Thermo Fisher Scientific's share price could fall to $495.43 by Jan 7, 2022. The average Thermo Fisher Scientific stock price prediction forecasts a potential downside of 1.53% from the current TMO share price of $503.14.

What is TMO's earnings growth forecast for 2021-2022?

(NYSE: TMO) Thermo Fisher Scientific's forecast annual earnings growth rate of 62.29% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 70.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 110.74%.

Thermo Fisher Scientific's earnings in 2020 is $4,879,000,000.On average, 10 Wall Street analysts forecast TMO's earnings for 2021 to be $7,896,755,603, with the lowest TMO earnings forecast at $7,001,932,380, and the highest TMO earnings forecast at $8,346,936,340.

In 2022, TMO is forecast to generate $7,752,563,267 in earnings, with the lowest earnings forecast at $7,120,609,200 and the highest earnings forecast at $8,588,245,874.

What is TMO's revenue growth forecast for 2021-2022?

(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 16.29% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 21.21%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 71.81%.

Thermo Fisher Scientific's revenue in 2020 is $28,497,000,000.On average, 7 Wall Street analysts forecast TMO's revenue for 2021 to be $13,108,987,737,042, with the lowest TMO revenue forecast at $12,753,992,138,912, and the highest TMO revenue forecast at $13,519,267,745,000.

In 2022, TMO is forecast to generate $13,054,706,146,342 in revenue, with the lowest revenue forecast at $12,619,301,860,000 and the highest revenue forecast at $13,467,758,049,226.

What is TMO's Earnings Per Share (EPS) forecast for 2021-2022?

(NYSE: TMO) Thermo Fisher Scientific's current Earnings Per Share (EPS) is $12.30. On average, analysts forecast that TMO's EPS will be $19.96 for 2021, with the lowest EPS forecast at $17.70, and the highest EPS forecast at $21.10. In 2022, TMO's EPS is forecast to hit $19.60 (min: $18.00, max: $21.71).

What is TMO's forecast return on equity (ROE) for 2021-2022?

(NYSE: TMO) forecast ROE is 24.36%, which is considered strong.

What is TMO's forecast return on assets (ROA) for 2021-2022?

(NYSE: TMO) forecast ROA is 12.1%, which is higher than the forecast US Diagnostics & Research industry average of 9.22%.
WallStreetZen
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatistics
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics